|
JP5496876B2
(ja)
|
2007-04-16 |
2014-05-21 |
アッヴィ・インコーポレイテッド |
７−置換されていないインドール系Ｍｃｌ−１阻害薬
|
|
US8114893B2
(en)
*
|
2008-12-19 |
2012-02-14 |
Genentech, Inc. |
Compounds and methods of use
|
|
US9526648B2
(en)
|
2010-06-13 |
2016-12-27 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US10420665B2
(en)
|
2010-06-13 |
2019-09-24 |
W. L. Gore & Associates, Inc. |
Intragastric device for treating obesity
|
|
US10010439B2
(en)
|
2010-06-13 |
2018-07-03 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US8628554B2
(en)
|
2010-06-13 |
2014-01-14 |
Virender K. Sharma |
Intragastric device for treating obesity
|
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
|
LT2710013T
(lt)
|
2011-05-20 |
2016-09-12 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Naujieji junginiai kaip diacilglicerolio aciltransferazės inhibitoriai
|
|
TWI561521B
(en)
*
|
2011-10-14 |
2016-12-11 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
US8940737B2
(en)
|
2011-10-14 |
2015-01-27 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
TWI571466B
(zh)
*
|
2011-10-14 |
2017-02-21 |
艾伯維有限公司 |
用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
|
|
US8889675B2
(en)
|
2011-10-14 |
2014-11-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
JP5955531B2
(ja)
*
|
2011-11-07 |
2016-07-20 |
千葉県 |
抗癌剤
|
|
CN107652289B
(zh)
|
2012-06-13 |
2020-07-21 |
因塞特控股公司 |
作为fgfr抑制剂的取代的三环化合物
|
|
CN103515415A
(zh)
*
|
2012-06-26 |
2014-01-15 |
群康科技(深圳)有限公司 |
叠层结构与其制造方法、以及包含其的电子装置
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
JP6225187B2
(ja)
*
|
2012-08-13 |
2017-11-01 |
アッヴィ・インコーポレイテッド |
アポトーシス誘発剤
|
|
MX2015002887A
(es)
*
|
2012-09-06 |
2015-07-06 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello.
|
|
ES2623304T3
(es)
|
2012-10-11 |
2017-07-10 |
F. Hoffmann-La Roche Ag |
Azaindolinas
|
|
US9796729B2
(en)
|
2012-11-23 |
2017-10-24 |
Glaxosmithkline Llc |
Compounds as diacylglycerol acyltransferase inhibitors
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
EP2970277B1
(en)
|
2013-03-15 |
2021-07-28 |
Knopp Biosciences LLC |
Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
|
|
JP6449244B2
(ja)
|
2013-04-19 |
2019-01-09 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｆｇｆｒ抑制剤としての二環式複素環
|
|
FR3008979B1
(fr)
*
|
2013-07-23 |
2015-07-24 |
Servier Lab |
Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR3008975A1
(fr)
|
2013-07-23 |
2015-01-30 |
Servier Lab |
Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
SG11201606239UA
(en)
|
2014-01-28 |
2016-08-30 |
Buck Inst For Res On Aging |
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
|
|
CN106456699B
(zh)
|
2014-05-05 |
2021-07-02 |
生物风险投资有限责任公司 |
作为抗老化剂抑制抗凋亡的Bcl-2蛋白的组合物和方法
|
|
EP3177144A4
(en)
|
2014-07-22 |
2018-01-24 |
Bioventures, LLC. |
Compositions and methods for selectively depleting senescent cells
|
|
SI3572405T1
(sl)
*
|
2014-09-12 |
2023-12-29 |
Biohaven Therapeutics Ltd. |
Amidi benzoimidazol-1,2-il kot aktivatorji kanalov kv 7
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
AU2015360613A1
(en)
*
|
2014-12-09 |
2017-06-29 |
Abbvie Inc. |
Bcl xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same
|
|
WO2016094517A1
(en)
*
|
2014-12-09 |
2016-06-16 |
Abbvie Inc. |
Bcl-xl inhibitory compounds and antibody drug conjugates including the same
|
|
WO2016131100A1
(en)
*
|
2015-02-18 |
2016-08-25 |
The Walter And Eliza Hall Institute Of Medical Research |
Methods of treating infectious diseases
|
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
US10195213B2
(en)
|
2015-03-13 |
2019-02-05 |
Unity Biotechnology, Inc. |
Chemical entities that kill senescent cells for use in treating age-related disease
|
|
WO2016172218A1
(en)
*
|
2015-04-20 |
2016-10-27 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of mcl-1 and uses thereof
|
|
CA2997556C
(en)
*
|
2015-09-03 |
2020-12-22 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of dyrk1a and uses thereof
|
|
AU2016355303B2
(en)
*
|
2015-11-20 |
2021-10-07 |
Mingsight Pharmaceuticals, Inc. |
Treatment of autoimmune disease
|
|
EP3445452A4
(en)
|
2016-04-21 |
2019-10-30 |
BioVentures, LLC |
COMPOUNDS FOR INDUCING THE DEGRADATION OF ANTIAPOPTOTIC PROTEINS OF THE BCL-2 FAMILY AND USES THEREOF
|
|
US10779980B2
(en)
|
2016-04-27 |
2020-09-22 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
TW202304996A
(zh)
|
2016-06-08 |
2023-02-01 |
美商艾伯維有限公司 |
抗-b7-h3抗體及抗體藥物結合物
|
|
WO2018029473A1
(en)
*
|
2016-08-09 |
2018-02-15 |
University Of Durham |
Synthetic retinoids (in cell modulation)
|
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
|
US20180072741A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyrimidine compounds and uses thereof
|
|
CN115819417A
(zh)
|
2016-09-09 |
2023-03-21 |
因赛特公司 |
作为hpk1调节剂的吡唑并吡啶衍生物及其用于治疗癌症的用途
|
|
WO2018092064A1
(en)
*
|
2016-11-18 |
2018-05-24 |
Novartis Ag |
Combinations of mdm2 inhibitors and bcl-xl inhibitors
|
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
|
CN108186642B
(zh)
*
|
2018-01-11 |
2019-11-08 |
广西师范大学 |
一种协同起作用治疗肺癌的药物组合物
|
|
US12118414B2
(en)
|
2018-01-22 |
2024-10-15 |
Bioventures, Llc |
BCL-2 proteins degraders for cancer treatment
|
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
DK3755703T3
(da)
|
2018-02-20 |
2022-06-27 |
Incyte Corp |
N-(phenyl)-2-(phenyl)pyrimidin-4-carboxamidderivater og relaterede forbindelser som hpk1-inhibitorer til behandling af kræft
|
|
US12528810B2
(en)
|
2018-03-01 |
2026-01-20 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of DYRK/CLK and uses thereof
|
|
BR112020018933A2
(pt)
|
2018-03-19 |
2020-12-29 |
Knopp Biosciences Llc |
Composto, composição farmacêutica, método de tratamento de um transtorno associado a kv7 e método de tratamento de um transtorno associado a uma mutação kcnq2
|
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
|
CN119241541A
(zh)
|
2018-05-04 |
2025-01-03 |
因赛特公司 |
Fgfr抑制剂的固体形式和其制备方法
|
|
PE20210919A1
(es)
|
2018-05-04 |
2021-05-19 |
Incyte Corp |
Sales de un inhibidor de fgfr
|
|
US12084423B2
(en)
|
2018-05-18 |
2024-09-10 |
Bioventures, Llc |
Piperlongumine analogues and uses thereof
|
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
|
ES2973117T3
(es)
|
2018-09-25 |
2024-06-18 |
Incyte Corp |
Compuestos de pirazolo[4,3-d]pirimidina como moduladores de ALK2 y/o FGFR
|
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
AR119494A1
(es)
*
|
2019-07-29 |
2021-12-22 |
Servier Lab |
DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS
|
|
JP2022543155A
(ja)
|
2019-08-06 |
2022-10-07 |
インサイト・コーポレイション |
Ｈｐｋ１阻害剤の固体形態
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
GEP20247679B
(en)
|
2019-10-14 |
2024-10-10 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
IL293001A
(en)
|
2019-12-04 |
2022-07-01 |
Incyte Corp |
Derivatives of fgfr repressors
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CN112079791A
(zh)
*
|
2020-08-21 |
2020-12-15 |
宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） |
单环β-内酰胺类抗生素侧链酸及其酯、其制备方法和应用
|
|
IL303048A
(en)
|
2020-11-24 |
2023-07-01 |
Novartis Ag |
Bcl-xl inhibitor antibody-drug conjugates and methods of use thereof
|
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
EP4288434A1
(en)
|
2021-02-02 |
2023-12-13 |
Les Laboratoires Servier |
Selective bcl-xl protac compounds and methods of use
|
|
JP2024513575A
(ja)
|
2021-04-12 |
2024-03-26 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
|
|
KR102605163B1
(ko)
*
|
2021-06-01 |
2023-11-23 |
연세대학교 산학협력단 |
뇌암의 예방 또는 치료용 조성물
|
|
AR126101A1
(es)
|
2021-06-09 |
2023-09-13 |
Incyte Corp |
Heterociclos tricíclicos como inhibidores de fgfr
|
|
WO2022261160A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
CN114294905B
(zh)
*
|
2021-11-19 |
2023-04-25 |
中粮生物科技股份有限公司 |
利用红外或微波干燥聚羟基脂肪酸酯的方法
|
|
CA3256012A1
(en)
|
2022-05-20 |
2023-11-23 |
Les Laboratoires Servier |
ANTIBODY-DRUG CONJUGATES, MET INHIBITORS BCL-XL, AND THEIR METHODS OF USE
|
|
KR20250027281A
(ko)
|
2022-05-20 |
2025-02-25 |
노파르티스 아게 |
Epha2 bcl-xl 억제제 항체-약물 접합체 및 그의 사용 방법
|
|
JP2025517435A
(ja)
|
2022-05-20 |
2025-06-05 |
ノバルティス アーゲー |
抗新生物薬化合物の抗体－薬物コンジュゲートおよびその使用の方法
|
|
EP4574175A1
(en)
*
|
2022-08-19 |
2025-06-25 |
Beijing Suncell Bio-Medical Co., Ltd. |
Prodrug for anti-aging related diseases and use method therefor
|
|
TW202540186A
(zh)
|
2023-11-22 |
2025-10-16 |
瑞士商諾華公司 |
抗ｃｄ７抗體藥物結合物及其使用方法
|
|
TW202540185A
(zh)
|
2023-11-22 |
2025-10-16 |
法商施維雅藥廠 |
抗cd74抗體藥物結合物及其使用方法
|
|
WO2025130875A1
(zh)
*
|
2023-12-18 |
2025-06-26 |
南京瑞初医药有限公司 |
氮杂环化合物及其应用
|